|
|
|
|
|
|
Levels |
Tepasse et al., Nutrients, doi:10.3390/nu13072173 (Peer Reviewed) |
death, ↓69.7%, p=0.04 |
Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis |
|
Details
Prospective analysis of 40 hospitalized patients and 47 age-matched convalescent patients, showing significantly lower vitamin A levels in critical patients, and significantly lower vitamin A levels in hospitalized patients vs. controls. .. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
| Tepasse et al., Nutrients, doi:10.3390/nu13072173 (Peer Reviewed) |
| Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis |
Prospective analysis of 40 hospitalized patients and 47 age-matched convalescent patients, showing significantly lower vitamin A levels in critical patients, and significantly lower vitamin A levels in hospitalized patients vs. controls. Low vitamin A levels were significantly associated with ARDS and mortality in hospitalized patients.
![]()
risk of death, 69.7% lower, RR 0.30, p = 0.04, treatment 4 of 29 (13.8%), control 5 of 11 (45.5%), OR converted to RR, >2mg/L, logistic regression.
risk of disease progression, 45.2% lower, RR 0.55, p = 0.05, treatment 13 of 29 (44.8%), control 9 of 11 (81.8%), OR converted to RR, progression to ARDS, >2mg/L, logistic regression.
Tepasse et al., 6/24/2021, prospective, Germany, Europe, peer-reviewed, 8 authors.
|
|
Submit Corrections or Comments
|
|
Late |
Sarohan et al., medRxiv, doi:10.1101/2021.01.30.21250844 (Preprint) |
death, ↑282.5%, p=0.001 |
Retinol Depletion in Severe COVID-19 |
|
Details
Retrospective 27 severe COVID-19 patients and 23 non-COVID-19 patients, showing signifcantly lower vitamin A levels in COVID-19 patients (0.37mg/L vs. 0.52 mg/L, p<0.001). 10 of 27 COVID-19 patients received vitamin A, with higher mortali.. |
|
Details
Source
PDF
Late treatment study
Late treatment study
|
| Sarohan et al., medRxiv, doi:10.1101/2021.01.30.21250844 (Preprint) |
| Retinol Depletion in Severe COVID-19 |
Retrospective 27 severe COVID-19 patients and 23 non-COVID-19 patients, showing signifcantly lower vitamin A levels in COVID-19 patients (0.37mg/L vs. 0.52 mg/L, p<0.001). 10 of 27 COVID-19 patients received vitamin A, with higher mortality. Group details are not provided but authors note that 8 of 10 had comorbidities.
![]()
risk of death, 282.5% higher, RR 3.83, p = 0.001, treatment 9 of 10 (90.0%), control 4 of 17 (23.5%).
Sarohan et al., 2/1/2021, retrospective, Turkey, Europe, preprint, 4 authors.
|
|
Submit Corrections or Comments
|
|
Early |
Al-Sumiadai, Systematic Reviews in Pharmacy, 12:1 (Preprint) |
progression, ↓66.7%, p=0.27 |
Therapeutic effect of vitamin A on COVID-19 patients and its prophylactic effect on contacts |
|
Details
Treatment and prophylaxis studies of vitamin A in Iraq.
The treatment study contained 100 patients, 50 treated with 200,000IU vitamin A for two days, showing lower progression to severe disease, and shorter duration of symptoms.
The pro.. |
|
Details
Source
PDF
Early treatment study
Early treatment study
|
| Al-Sumiadai, Systematic Reviews in Pharmacy, 12:1 (Preprint) |
| Therapeutic effect of vitamin A on COVID-19 patients and its prophylactic effect on contacts |
Treatment and prophylaxis studies of vitamin A in Iraq.The treatment study contained 100 patients, 50 treated with 200,000IU vitamin A for two days, showing lower progression to severe disease, and shorter duration of symptoms.The prophylaxis study contained 209 contacts of COVID-19 patients, 97 treated with vitamin A, showing significantly lower cases with treatment, and shorter duration of symptoms.
![]()
risk of disease progression, 66.7% lower, RR 0.33, p = 0.27, treatment 2 of 50 (4.0%), control 6 of 50 (12.0%), progression to severe disease.
recovery time, 37.5% lower, relative time 0.62, treatment 50, control 50.
Al-Sumiadai et al., 1/31/2021, prospective, Iraq, Middle East, preprint, 3 authors.
|
|
Submit Corrections or Comments
|
|
Review |
Stephensen et al., British Journal of Nutrition, doi:10.1017/S0007114521000246 (Review) (Peer Reviewed) |
review |
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2 |
|
Details
Review of the potential benefits of vitamin A for COVID-19, including maintaining innate and adaptive immunity, minimizing inflammation, supporting repair of respiratory epithelium and preventing fibrosis, and counteracting adverse effect.. |
|
Details
Source
PDF
Review
Review
|
| Stephensen et al., British Journal of Nutrition, doi:10.1017/S0007114521000246 (Review) (Peer Reviewed) |
| Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2 |
Review of the potential benefits of vitamin A for COVID-19, including maintaining innate and adaptive immunity, minimizing inflammation, supporting repair of respiratory epithelium and preventing fibrosis, and counteracting adverse effects of SARS-CoV-2 on the angiotensin system.
![]()
Stephensen et al., 1/20/2021, peer-reviewed, 2 authors.
|
|
Submit Corrections or Comments
|
|
Early |
Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350 (Peer Reviewed) |
death, ↓85.7%, p=0.002 |
Therapeutic effect of Vitamin A on severe COVID-19 patients |
|
Details
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A. |
|
Details
Source
PDF
Early treatment study
Early treatment study
|
| Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350 (Peer Reviewed) |
| Therapeutic effect of Vitamin A on severe COVID-19 patients |
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A.
![]()
risk of death, 85.7% lower, RR 0.14, p = 0.002, treatment 2 of 70 (2.9%), control 14 of 70 (20.0%).
Al-Sumiadai et al., 12/31/2020, retrospective, Iraq, Middle East, peer-reviewed, 3 authors.
|
|
Submit Corrections or Comments
|
|
Review |
Midha et al., Reviews in Medical Virology, doi:10.1002/rmv.2204 (Review) (Peer Reviewed) |
review |
Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings |
|
Details
Review of the potential benefits of vitamin A for COVID-19, including the effect of vitamin A on ACE2 expression in the respiratory tract, potentially improving the generation of protective immune responses to vaccines, and dosage and saf.. |
|
Details
Source
PDF
Review
Review
|
| Midha et al., Reviews in Medical Virology, doi:10.1002/rmv.2204 (Review) (Peer Reviewed) |
| Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings |
Review of the potential benefits of vitamin A for COVID-19, including the effect of vitamin A on ACE2 expression in the respiratory tract, potentially improving the generation of protective immune responses to vaccines, and dosage and safety analysis.
![]()
Midha et al., 12/31/2020, peer-reviewed, 4 authors.
|
|
Submit Corrections or Comments
|
|
Levels |
Tomasa-Irriguible et al., Metabolites, doi:10.3390/metabo11090565 (preprint 10/26/2020) (Peer Reviewed) |
ventilation, ↓71.4%, p=0.001 |
Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave |
|
Details
Retrospective 120 hospitalized patients in Spain showing vitamin A deficiency associated with higher ICU admission. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
| Tomasa-Irriguible et al., Metabolites, doi:10.3390/metabo11090565 (preprint 10/26/2020) (Peer Reviewed) |
| Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave |
Retrospective 120 hospitalized patients in Spain showing vitamin A deficiency associated with higher ICU admission.
![]()
risk of mechanical ventilation, 71.4% lower, RR 0.29, p = 0.001, treatment 4 of 34 (11.8%), control 48 of 86 (55.8%), adjusted, OR converted to RR, ≥0.3 mg/L, multivariate logistic regression.
risk of ICU admission, 61.3% lower, RR 0.39, p = 0.004, treatment 6 of 34 (17.6%), control 54 of 86 (62.8%), adjusted, OR converted to RR, ≥0.3 mg/L, multivariate logistic regression.
Tomasa-Irriguible et al., 10/26/2020, retrospective, Spain, Europe, peer-reviewed, 7 authors.
|
|
Submit Corrections or Comments
|
|
In Silico |
Li et al., Aging, doi:10.18632/aging.103888 (Peer Reviewed) |
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19 |
|
Details
Bioinformatics and network pharmacology analysis identifying potential mechanisms of action of vitamin A for COVID-19. |
|
Details
Source
PDF
In Silico
In Silico
|
| Li et al., Aging, doi:10.18632/aging.103888 (Peer Reviewed) |
| Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19 |
Bioinformatics and network pharmacology analysis identifying potential mechanisms of action of vitamin A for COVID-19.
![]()
Li et al., 8/15/2020, peer-reviewed, 7 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
|
|
Submit Corrections or Comments
|
